CELEMICS

Live / Registered — Registered (as of 24 Jun 2025)

What this means for you

Registered since 24 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98018569
Registration number
7845163
Mark type
Design + words
Filed
30 May 2023
Published for opposition
30 Jul 2024
Registered
24 Jun 2025
Attorney of record
minchul yang

Goods and services

  • Class 005 — Pharmaceuticals: Biotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; chemical preparations for use in DNA analysis for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; in vitro diagnostic preparations for medical purposes; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing.
  • Class 042 — Scientific and technological services: Research and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; chemical research; research for medical products, namely, medical research; scientific research in the nature of conducting clinical trials for others in the field of oncology, cardiovascular disease, neurology, immunology, and genomics; biotechnology research; biochemical research; providing information of scientific research.

Owner

Prosecution history

  • 24 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 24 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
  • 04 Jun 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 04 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 02 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 09 Mar 2025 — USE AMENDMENT FILED
  • 03 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 10 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
  • 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 30 Jul 2024 — PUBLISHED FOR OPPOSITION
  • 10 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 12 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 12 Jun 2024 — EXAMINER'S AMENDMENT ENTERED
  • 12 Jun 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

View this trademark record on Marksy